Events | 2021.05.20
GB HealthWatch Launches Nutritional Genomics Analysis within Digital Health Platform to Combat Coronary Heart Disease, Obesity and Type 2 Diabetes
GB HealthWatch announces the launch of GBinsight nutritional genomics genetic testing and analysis at the core of their digital health platform which has been designed to combat common cardiometabolic diseases. Adding nutritional genomics to the company’s extensive next-generation sequencing (NGS)-based genetic test catalog was a strategic step for GB HealthWatch to expand into the arena of genetics-based, precision preventive healthcare.
(PRWeb May 20, 2021)
Read the full story at https://www.prweb.com/releases/gb_healthwatch_launches_nutritional_genomics_analysis_within_digital_health_platform_to_combat_coronary_heart_disease_obesity_and_type_2_diabetes/prweb17938847.htm
For more information, please visit
https://www.prweb.com/releases/gb_health[...]e_2_diabetes/prweb17938847.htm
